MIRA
INFORM REPORT
|
Report Date : |
31.10.2007 |
IDENTIFICATION
DETAILS
|
Name : |
MILLE MEDITECH CO., LTD. |
|
|
|
|
Registered Office : |
1st Fl., 1603-1, Seocho 1-dong, Seocho-gu, Seoul - 137-877 |
|
|
|
|
Country : |
Korea |
|
|
|
|
Date of Incorporation : |
02/23/2001 |
|
|
|
|
Legal Form : |
Company Limited by shares |
|
|
|
|
Line of Business : |
Wholesale of Medical, Professional and Scientific Instruments and
Equipment |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
Basic
|
Company
Name |
MILLE MEDITECH CO., LTD. |
|
Registered Address |
1st Fl., 1603-1, Seocho 1-dong, Seocho-gu,
Seoul, Korea |
|
Zip Code |
137-877 |
|
Tel |
+82-2-597-8160 |
|
Fax |
+82-2-597-8163 |
|
E-mail |
has76@hanmail.net |
|
Trading Address |
1st Fl., 1603-1, Seocho 1-dong, Seocho-gu,
Seoul, Korea |
|
Tel |
+82-2-597-8160 |
|
Fax |
+82-2-597-8163 |
|
Type |
Import/Export |
|
Industry |
Wholesale of Medical, Professional and Scientific Instruments and
Equipment |
|
Sub Business |
General Tour Service |
|
Established (mm/dd/yyyy) |
02/23/2001 |
Detailed Products
|
Activity |
Detailed Products (UNSPSC) |
|
Sell |
Prosthetic devices or accessories and
supplies(42242000) |
|
Sell |
Tour Service |
CEO’s
|
Name |
Hwang Jae-Won |
|
Address |
855, Sanghyeon-dong ,Suji-gu ,Yongin-si,
Gyeonggi-do, Korea |
|
Date of Birth |
01/18/1966 |
|
Title |
President & CEO |
|
Sex |
Male |
|
Nationality |
Korean |
Profiles
|
Capital |
220,000,000 KRW |
|
Employees |
5 |
|
Formation |
Co., Ltd by shares |
|
Bank Details |
Shinhan Bank |
|
Corporate Registered No. |
110111-2178047 |
|
Business Registered No. |
114-86-06423 |
|
Permit & Licenses |
N/A |
|
Shareholder Position |
N/A |
|
Company History |
02/23/2001 Incorporated
as the present name 11/16/2006
Moved to the present address from 1598-3, Seocho-dong, Seocho-gu, Seoul, Korea |
|
|
|
Management
|
Job Description |
Title |
Name |
Sex |
Nationality |
Inauguration Day |
|
President & CEO |
Mr. |
Hwang Jae-Won |
Male |
Korean |
11/16/2006 |
|
Director |
M/S. |
Kim Hye-Young |
Female |
Korean |
08/30/2005 |
|
Auditor |
Mr. |
Hwang Ahn-Seob |
Male |
Korean |
09/27/2007 |
Financials
The latest financial is not available.
Financial Description
Unit: KRW
|
Authorized
Capital |
880,000,000 |
|
Paid-Up
Capital |
220,000,000 |
|
Total Issues Shares |
176,000 |
Products, Technologies, Services
Description
|
Main
Products & Services |
Interbody Fusion Cage |
Trade
Partners
|
Suppliers |
SPINE NEXT |
Sales by
Region (Activity &
Markets)
The Subject imports medical materials and tools from France.
Court
Action
Not Available.
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)